MindWalk Holdings Corp.

HYFT Biotech & pharma

Develops AI-driven platforms for drug discovery and development.

Apr 2025Revenue C$24.5M/yrExpenses C$58.8M/yr
No trend
Figures by year

When will MindWalk Holdings be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Apr 2025, revenue was C$24.5M and expenses C$58.8M.

Fiscal year toRevenueExpensesPre-tax profit
Apr 2025C$24.5MC$58.8M−C$34.3M
Apr 2024C$24.5MC$53.2M−C$28.7M
Apr 2023C$20.7MC$48.4M−C$27.8M
Apr 2022C$19.4MC$35.2M−C$15.8M
Apr 2021C$17.9MC$23.9M−C$6.00M
Apr 2020C$14.1MC$19.4M−C$5.29M